Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.


Gorczynski R. M., Chen Z., ERİN N., Khatri I., Podnos A.

PloS one, vol.9, no.11, 2014 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 9 Issue: 11
  • Publication Date: 2014
  • Doi Number: 10.1371/journal.pone.0113597
  • Journal Name: PloS one
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Akdeniz University Affiliated: Yes

Abstract

Purpose: We have compared cure from local/metastatic tumor growth in BALB/c mice receiving EMT6 or the poorly immunogenic, highly metastatic 4THM, breast cancer cells following manipulation of immunosuppressive CD200:CD200R interactions or conventional chemotherapy.